Gene · 4082
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Aberrant Expression of Gemcitabine-Targeting Proteins in Drug-Resistant Cells Using an Activity-Based Gemcitabine Probe. | ACS Chem Biol | 2024 | 39465385 | PubTator, text mining | PubMed |
| Mycobacterium avium inhibits protein kinase C and MARCKS phosphorylation in human cystic fibrosis and non-cystic fibrosis cells. | PLoS One | 2024 | 39413095 | PubTator, text mining | PubMed |
| Enhanced understanding of cinnamaldehyde's therapeutic potential in osteoarthritis through bioinformatics and mechanistic validation of its anti-apoptotic effect. | Front Med (Lausanne) | 2024 | 39376659 | PubTator, text mining | PubMed |
| A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate promotes neuronal differentiation in SH-SY5Y human neuroblastoma cells. | J Vet Med Sci | 2024 | 39343539 | PubTator, text mining | PubMed |
| The role of RNA modifications in disease-associated macrophages. | Mol Ther Nucleic Acids | 2024 | 39296330 | PubTator, text mining | PubMed |
| Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma. | Discov Oncol | 2024 | 39292372 | PubTator, text mining | PubMed |
| Stretch triggers microtubule stabilization and MARCKS-dependent membrane incorporation in the shaft of embryonic axons. | Curr Biol | 2024 | 39265571 | PubTator, text mining | PubMed |
| Spatial characterization and stratification of colorectal adenomas by deep visual proteomics. | iScience | 2024 | 39252972 | PubTator, text mining | PubMed |
| Inhibition of MARCKS phosphorylation attenuates of dendritic cell migration in a murine model of acute asthma. | Eur J Pharmacol | 2024 | 39111683 | PubTator, text mining | PubMed |
| Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury. | Sci Immunol | 2024 | 39093958 | PubTator, text mining | PubMed |
| Revolutionary Point-of-Care Wearable Diagnostics for Early Disease Detection and Biomarker Discovery through Intelligent Technologies. | Adv Sci (Weinh) | 2024 | 38958517 | PubTator, text mining | PubMed |
| Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine. | Pharmaceutics | 2024 | 38931833 | PubTator, text mining | PubMed |
| Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing. | Front Immunol | 2024 | 38903524 | PubTator, text mining | PubMed |
| Synthetic control of actin polymerization and symmetry breaking in active protocells. | Sci Adv | 2024 | 38865458 | PubTator, text mining | PubMed |
| Exosomes derived from pulmonary metastatic sites enhance osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS. | Acta Pharm Sin B | 2024 | 38799644 | PubTator, text mining | PubMed |
| CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation. | Mol Cancer | 2024 | 38755678 | PubTator, text mining | PubMed |
| PIP2 Is An Electrostatic Catalyst for Vesicle Fusion by Lowering the Hydration Energy: Arresting Vesicle Fusion by Masking PIP2. | ACS Nano | 2024 | 38717305 | PubTator, text mining | PubMed |
| LINC01133 regulates MARCKS expression via sponging miR-30d-5p to promote the development of lung squamous cell carcinoma. | Transl Oncol | 2024 | 38599002 | PubTator, text mining | PubMed |
| PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery. | J Chem Inf Model | 2024 | 38404138 | PubTator, text mining | PubMed |
| The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming. | Front Immunol | 2024 | 38288308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4082/papers?page=5